Clinical trial Recruiting at 1 site Observational Ages 4 to 70

Robot-assisted walking treatment for hereditary spastic paraplegia

Official title: Efficacy of Robot-assisted Walking Treatment on Gait Biomechanics, Functional Outcomes, and Quality of Life in Subjects With Hereditary Spastic Paraplegia (HSP)

Run by IRCCS Eugenio Medea · NCT06728787 · Data updated 2026-11-12

This study is testing whether using a robot to help with walking, along with regular physical therapy, can improve movement and quality of life for people with hereditary spastic paraplegia.

Quick facts

Study typeObservational
Ages4 Years to 70 Years
SexAll
Enrollment50 (estimated)
SponsorIRCCS Eugenio Medea
Academic / other
Locations1 site (Bosisio Parini, Italy/lecco)
StatusRecruiting
StartedJanuary 1, 2012
Main results expectedDecember 31, 2026
Study endsDecember 31, 2026
Registry record updatedMay 4, 2025
Trial IDNCT06728787 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include individuals aged 4 to 70 with a genetic or clinical diagnosis of hereditary spastic paraplegia who can walk independently.

Probably not a fit

Patients with severe lower limb muscle retractions, recent lower limb surgeries, or acute neurological disorders may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study evaluates the effectiveness of a combined rehabilitation approach using the Lokomat robotic gait training system alongside traditional physical therapy for patients with hereditary spastic paraplegia (HSP). Participants will undergo a total of 30 sessions over three weeks, with assessments conducted before, after treatment, and at a three-month follow-up. The study aims to measure improvements in gait, functional abilities, and quality of life through various clinical-functional assessments. This approach seeks to enhance the rehabilitation experience and outcomes for individuals affected by this rare neurological disorder.

Why it matters

Potential benefit: If successful, this treatment could significantly improve mobility and quality of life for patients with hereditary spastic paraplegia.

How similar studies have gone: Previous studies using robotic gait training in neurological disorders have shown promising results, suggesting potential efficacy for this approach in hereditary spastic paraplegia.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* genetic or clinical diagnosis of HSP.
* age greater than 4 years and less than 70
* femur length \> 23 cm
* ability to walk independently indoors, with or without walking aids.

Exclusion Criteria:

* botulinum toxin injection or lower limb surgery in the previous 6 months
* severe lower limb muscle retractions
* severe osteoporosis
* unhealed skin lesions in lower limbs
* cardiovascular instability
* acute or progressive neurological disorders
* behavioral problemS

Where it's running

  • Irccs Eugenio Medea
    Bosisio Parini, Italy/lecco, Italy
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.